« Maharashtra FDA fully in compliance with DCGI order (PharmaBiz) The | Main | FDA Approvals - Welcome to the New Era of FDA Regulation (The Motley »

FDA Issues Early Communication for Chantix FDA is evaluating postmarketing


FDA Issues Early Communication for Chantix
FDA is evaluating postmarketing adverse event reports for Chantix (varenicline), a prescription medicine to help adults stop smoking.
 

©2006 FDA-News.com. All rights reserved.